Skip to main content

Table 1 Clinical characteristic of LUSC (n = 501) from TCGA database

From: A glycolysis-based three-gene signature predicts survival in patients with lung squamous cell carcinoma

Clinical characteristic

N

%

Age

  ≤ 65

190

37.9

  > 65

302

60.3

 NA

9

1.8

Sex

 Female

130

25.9

 Male

371

74.1

AJCC stage

 I

3

0.6

 IA

90

18.0

 IB

151

30.1

 II

3

0.6

 IIA

65

13.0

 IIB

94

18.8

 III

3

0.6

 IIIA

63

12.6

 IIIB

18

3.6

 IV

7

1.4

 NA

4

0.8

T

 T1

114

22.7

 T2

293

58.5

 T3

71

14.2

 T4

23

4.6

N

 N0

319

63.7

 N1

131

26.1

 N2

40

8.0

 N3

5

1.0

 NA

6

1.2

M

 M0

411

82.0

 M1

7

1.4

 NA

83

16.6

Survival time

 Reported

495

98.8

 NA

6

1.2

Survival status

 Alive

286

57.1

 Dead

215

42.9

  1. Abbreviations: LUSC Lung squamous cell carcinoma, TCGA The cancer genome atlas, NA Not available, AJCC American joint committee on cancer